AN69ST Verse PS in CBP in Septic Children
Key facts
- Who runs it
- Children's Hospital of Fudan University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 1 Oct 2025
- Expected to end
- 31 Dec 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- blood purification(PS)
- blood purification(AN69ST)
- Record updated
- 17 February 2026
Who can take part
- Age
- 29 days to 28 years
- Sex
- Women and men
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Meet the 2005 diagnostic criteria for sepsis
- Age 29 days - 18 years old
- Sepsis-induced dysfunction of more than one organ or abnormal tissue perfusion, or septic shock
- Diagnosis < 48 hours
Who cannot take part
- Subject has received chemoradiotherapy or immunosuppressive therapy in the 14 days before enrollment
- Subject is currently enrolled in an investigational drug or device trial
- Subject has been previously enrolled in the current trial
- Subject has received organ transplantation
- Subject has end-stage renal disease and requires chronic dialysis
- Subject has uncontrolled hemorrhage
- Subject has immunodeficiency diseases
- Subject has known sensitivity or allergy to heparin or has a history of heparin associated thrombocytopenia
- Any other condition, that in the opinion of the investigator, would preclude the subject from being a suitable candidate for enrollment, such as end stage chronic illness with no reasonable expectation of survival to hospital discharge
- Known hypersensitivity to hemofilter
- HIV infection in association with a last known or suspected CD4 count of <50/mm3
- Inability to obtain an informed consent from the subject, family member or an authorized surrogate
- There is clinical support for non-septic shock
- Subject has had chest compressions as part of cardiopulmonary resuscitation this hospitalization without immediate return to communicative state
- Subject has sustained extensive third-degree burns within the past 7 days
- Subject is expected to die within 24 hours
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In septic shock, dysregulated host responses to pathogens lead to cytokine storms that damage host tissues and organs, further contributing to the development of organ dysfunction and increased mortality. For sepsis, blood purification can remove inflammatory factors in sepsis by filtration or adsorption, so as to achieve the purpose of reducing inflammatory mediators in the body. However, there are few prospective randomized controlled studies in children. Therefore, this study intends to compare the efficacy and prognosis of different membrane on children with sepsis through a perspective cohort study, so as to provide a corresponding basis for the treatment of children with sepsis blood purification.
The 2 groups in the trial
- blood purification(AN69ST)
- blood purification(PS)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effects of a AN69ST Membrane and Polysulphone Membrane on Septic Children With Continuous Blood Purification
- Record updated
- 17 February 2026